杂志简称：j nat med、tokyo
中文译名：《天然药物杂志》
收录属性：scie（2024版）, 目次收录（维普）, 目次收录（知网）,英文期刊,
自引率：7.90%
投稿方向：医学、pharmacology & pharmacy药学
SCI/E期刊基本信息
出版周期：季刊 地区：日本
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN 1340-3443;EISSN 1861-0293
杂志语言：英语
出版国家：日本
杂志官网 联系方式
出版地址：SHIROYAMA TRUST TOWER 5F,4-3-1 TORANOMON,MINATO-KU,TOKYO,JAPAN,105-6005
杂志邮箱：
投稿网址：https://www.editorialmanager.com/jonm/default1.aspx
杂志官方网址：https://www.springer.com/journal/11418
出版商网址：http://www.springer.com
杂志投稿要求
投稿须知【杂志社官方网站信息】
JOURNAL OF NATURAL MEDICINES
Instructions for Authors
Editorial policy
Before preparation of your manuscript, read the 'Instructions for Authors' carefully. We will not accept manuscripts that do not comply with these instructions.
The Journal of Natural Medicines invites papers that make a significant contribution to the knowledge and understanding of naturally occurring medicines and their related foods and cosmetics, including identification and structure elucidation of natural products, biosynthesis, biotechnology, and pharmacology of herbs, natural products, and Kampo formulas. Papers are also published concerning chemical and botanical identification of herbs or their products where such information contributes to the overall safety of plant-based medicines currently and/or formerly in use. Submission of a paper implies that it has been approved by all the named authors, that it has not been published before, and that it is not under consideration for publication elsewhere.
Acceptance of papers will be decided by the Editorial Board after examination by at least two referees. Manuscripts that require revision and/or correction and/or condensation will be returned to the authors with comments specifying alterations from the referees and/or the Editorial Board.
The following types of papers may be submitted.
(i) Original Papers: Original Papers are the usual form of publication of this journal describing original experimental results.
(ii) Notes (up to 4 printed pages): Notes are brief articles reporting new facts and/or valuable data.
(iii) Rapid Communications (up to 3 printed pages): These are short preliminary reports of novel and significant findings that merit urgent publication. Full details of the Rapid Communication may be published later as a comprehensive original paper, in this or another journal. An explanatory statement is required for urgent publication. The statement should be submitted alongside the manuscript as its own file. Select the Item Type 'Article Type Explanatory Statement' when uploading the file.
(iv) Reviews (up to 12 printed pages): Reviews cover recent discoveries or topics of current interest.
(v) Mini-Reviews (up to 6 printed pages): These provide a short overview of a particular subject. In the case of a non-invited Review or Mini-Review, a short summary describing the outline should be sent to the Chief Editor for approval before submitting a manuscript.
(vi) Natural Resource Letters (up to 6 printed pages): Natural Resource Letters are reports on biological screening data, field observations, market surveys, quality evaluation or quantitative methods of crude drugs, etc., which may contribute to the scientific knowledge of the readers. An explanatory statement is required for publication as a Natural Resource Letter. The statement should be submitted alongside the manuscript as its own file. Select the Item Type 'Article Type Explanatory Statement' when uploading the file.
Documentation of experimental biological materials
Use the correct scientific name and indicate who identified the biological materials. The herbarium deposit site and voucher number should be recorded. Authors who purchase herbal materials from companies must make provision for their deposit in a herbarium.
Pharmacological investigations of extracts require detailed extract characterization
This includes botanical characterization of plant material(s), solvent(s), duration and temperature of extraction, plus other method(s) used for preparation(s). A chromatographic (e.g., HPLC profile recorded at different wavelengths) or chemical characterization (quantities of typical constituents) must be presented. The investigation must clearly indicate a dose/activity dependence in comparison with a reference compound (positive control) together with the appropriate statistics. Authors must mention it in the main text if there was no appropriate reference compound available.
Criteria of Authorship
Authorship should be based on the International Committee of Medical Journal Editors (ICJME) recommendations concerning authorship. All authors are required to meet the following 4 criteria:
Substantial contribution to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
……